Key result
Obesity drives metabolic derangements including insulin resistance and dyslipidaemia that heighten cardiovascular risk and mortality.
Obesity is a major and growing global health problem. It is associated with increased mortality as a result of an increasing number of complications, including type 2 diabetes, dyslipidaemia, hypertension, non-alcoholic hepatic steatosis, cardiovascular disease, sleep apnoea, gallbladder disease, obesity-related renal disease, increased risk of falls and injuries, and mental health problems as well as increased risk of certain malignancies. This article discusses the metabolic derangements associated with obesity. These include insulin resistance, dysglycaemia, low and dysfunctional high-density lipoprotein, formation of small dense and oxidised low-density lipoprotein, and high circulating levels of free fatty acids. This article reviews the aetiology of these derangements and their relationship to cardiovascular disease, and discusses the concept of metabolic health.
No takes yet. Share an insight, caveat, or question.
Fava et al. (2019) conducted a review in Obesity and cardio-metabolic health. Obesity was evaluated on Metabolic derangements and cardiovascular disease. Obesity is associated with insulin resistance, dysglycaemia, dyslipidaemia, and elevated free fatty acids that contribute to cardiovascular disease and mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: